You are here: Industry Insights > Sputnik V

News List

Second batch of Sputnik V COVID-19 vaccine reaches Hyderabad expresspharma
May 17, 2021
60,000 doses of Russia’s COVID-19 vaccine Sputnik V landed at Rajiv Gandhi International Airport here, Dr Reddy’s Laboratories said.
Over two billion doses of COVID-19 vaccines to be available between August to December 2021: Centre expresspharma
May 14, 2021
The Centre said that over two billion doses will be made available in the country in five months between August and December, enough to vaccinate the entire population.
India will study claim of Sputnik Light: Dr VK Paul expresspharma
May 10, 2021
India will examine the claim that a single dose of Russian vaccine ‘Sputnik Light’ can provide protection from the novel coronavirus infection, said NITI Aayog member V K Paul.
Russia authorises use of single-dose Covid-19 vaccine Sputnik Light pharmaceutical-technology
May 08, 2021
Sputnik Light, which is based on the human adenoviral vector platform, is the first component, a recombinant human adenovirus serotype number 26 (rAd26), of the Sputnik V Covid-19 vaccine.
Brazil’s Anvisa rejects import of Russia’s Covid-19 vaccine pharmaceutical-technology
April 28, 2021
The Brazilian National Health Surveillance Agency (Anvisa) has rejected the import of the Russian Covid-19 vaccine, Sputnik V, citing a lack of consistent and reliable data.
RDIF and Minapharm agree to produce over 40 million doses of the Sputnik V vaccine in Egypt prnasia
April 22, 2021
The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund), Egypt's Minapharm, the regional leader in recombinant DNA technology, and its Berlin-based subsidiary, ProBioGen AG, announce the agreement to produce over 40 million doses per ...
India to waive 10 per cent import duty on COVID-19 vaccines: Govt source expresspharma
April 22, 2021
Imports of Russia's Sputnik V vaccine are due to arrive soon and the government has also urged Pfizer, Moderna and Johnson and Johnson to sell their products to India.
Russia’s Sputnik V Covid-19 vaccine shows 97.6% efficacy pharmaceutical-technology
April 20, 2021
The Gamaleya National Research Center of Epidemiology and Microbiology and the Russian Direct Investment Fund (RDIF) have reported that the Sputnik V Covid-19 vaccine showed a 97.6% efficacy.
RDIF, Hualan Ink COVID-19 Vaccine Deal contractpharma
April 20, 2021
The Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, and Hualan Biological Bacterin Inc., a subsidiary company of one of China’s leading biopharmaceutical producers and the largest influenza vaccine manufacturer ...
Working on stability data on 2 to 8 C, temp range for Sputnik V vaccine: Dr Reddy’s expresspharma
April 16, 2021
He said necessary cold storage infrastructure is in place to distribute the Sputnik V vaccine in India, which would be available during this quarter.

Previous page 1 2 3 4 5 6 7 8 Next page